Product Introduction
IMDM(Iscove’s Modified Dulbecco Medium)is an improved DMEM medium, which is used for the culture of erythrocyte progenitor cells and macrophages. The IMDM medium was supplemented with selenium, HEPES, sodium pyruvate and additional amino acids and vitamins on the basis of the DMEM medium, and potassium nitrate instead of iron nitrate, which is suitable for the rapid proliferation, high-density cell culture. IMDM medium can not only culture cells with special nutritional requirements (such as mouse B lymphocytes, stimulated B cells stimulated by LPS, bone marrow hematopoietic cells, T lymphocytes and various hybridoma cells), It can also be used as a base solution for some unique serum-free medium. This product contains many kinds of amino acids, vitamins, inorganic salts and other ingredients for cell culture, but does not contain protein, lipids or any growth factors. Therefore, the product should be used with serum or serum-free additives.
Ingredient Statement
With
• 4500mg/L D-Glucose
• 25mM HEPES
• 4mM L-Glutamine
• 3024mg/L NaHCO3
• 1mM Sodium Pyruvate
• 15mg/L Phenol Red
Matters Need Attention
1. This product is for research use only.
2. This product is sterilized by 0.1μm filtration.
3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture.
Specifications | |
Concentration | 1× |
Volume | 500mL |
Form | Liquid |
Bacteria Detection | Negative |
Fungi Detection | Negative |
Mycoplasma Detection | Negative |
Endotoxin Content | <3 |
pH | 7.2-7.4 |
Animal Origin Ingredient | Without |
Green_Features | Sustainable packaging |
Cell Lines | HL-60, K-562 [K562], KATO III [KATO 3], Capan-1 |
Valid Period | 24 months |
Storage Condition | 2~8℃, shading light |
Shipping Condition | RT |
Related Products
Documents
Citations
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation
IF: 9.995LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit
IF: 9.685Author:Yanling Tao, Jingjing Zhang, Lulu Chen
Journal:Cell Death & Disease